Fortified Tregs to fight atherosclerosis.
作者信息
Ley Klaus
机构信息
Inflammation Biology Laboratory, La Jolla Institute for Immunology, La Jolla, CA, USA.
出版信息
Cardiovasc Res. 2021 Jul 27;117(9):1987-1988. doi: 10.1093/cvr/cvab103.
Abstract
摘要
相似文献
1
Fortified Tregs to fight atherosclerosis.强化调节性T细胞对抗动脉粥样硬化。
Cardiovasc Res. 2021 Jul 27;117(9):1987-1988. doi: 10.1093/cvr/cvab103.
2
Regulatory T Cells License Macrophage Pro-Resolving Functions During Atherosclerosis Regression.调节性 T 细胞在动脉粥样硬化消退过程中许可巨噬细胞发挥促修复功能。
Circ Res. 2020 Jul 17;127(3):335-353. doi: 10.1161/CIRCRESAHA.119.316461. Epub 2020 Apr 27.
3
Changes in CD4CD25 Tregs in the pathogenesis of atherosclerosis in ApoE mice.载脂蛋白E基因敲除小鼠动脉粥样硬化发病机制中CD4CD25调节性T细胞的变化
Exp Biol Med (Maywood). 2017 May;242(9):918-925. doi: 10.1177/1535370216689826. Epub 2017 Jan 1.
4
IgM antibodies against phosphorylcholine promote polarization of T regulatory cells from patients with atherosclerotic plaques, systemic lupus erythematosus and healthy donors.针对磷酸胆碱的 IgM 抗体可促进动脉粥样硬化斑块、系统性红斑狼疮和健康供体患者中 T 调节细胞的极化。
Atherosclerosis. 2018 Jan;268:36-48. doi: 10.1016/j.atherosclerosis.2017.11.010. Epub 2017 Nov 16.
5
Plaque vulnerability and adverse outcomes: The long road to fight atherosclerosis.斑块易损性与不良后果：对抗动脉粥样硬化的漫长之路
Eur J Clin Invest. 2020 Jun;50(6):e13253. doi: 10.1111/eci.13253. Epub 2020 May 15.
6
Plaque-reactive autoantibody A12 protects against atherosclerosis.斑块反应性自身抗体A12可预防动脉粥样硬化。
Nat Rev Cardiol. 2021 Mar;18(3):151. doi: 10.1038/s41569-020-00494-0.
7
B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice.CTB-p210 处理后的 B 细胞在体外获得调节表型，并减少载脂蛋白 E 缺陷小鼠的动脉粥样硬化。
Vascul Pharmacol. 2018 Dec;111:54-61. doi: 10.1016/j.vph.2018.09.002. Epub 2018 Sep 19.
8
Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice.黑皮质素系统的药理学激活可限制动脉粥样硬化小鼠斑块炎症并改善血管功能障碍。
Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):1346-54. doi: 10.1161/ATVBAHA.113.302963. Epub 2014 May 1.
9
Inhibition of Local Macrophage Growth Ameliorates Focal Inflammation and Suppresses Atherosclerosis.抑制局部巨噬细胞生长可改善局灶性炎症并抑制动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2018 May;38(5):994-1006. doi: 10.1161/ATVBAHA.117.310320. Epub 2018 Mar 1.
10
Altered Tregs Differentiation and Impaired Autophagy Correlate to Atherosclerotic Disease.调节性 T 细胞分化改变和自噬受损与动脉粥样硬化疾病相关。
Front Immunol. 2020 Mar 13;11:350. doi: 10.3389/fimmu.2020.00350. eCollection 2020.
引用本文的文献
1
Nano Delivery System for Atherosclerosis.用于动脉粥样硬化的纳米递送系统
J Funct Biomater. 2024 Dec 24;16(1):2. doi: 10.3390/jfb16010002.
2
Causal relationship between immune cells and risk of myocardial infarction: evidence from a Mendelian randomization study.免疫细胞与心肌梗死风险之间的因果关系：一项孟德尔随机化研究的证据
Front Cardiovasc Med. 2024 Aug 27;11:1416112. doi: 10.3389/fcvm.2024.1416112. eCollection 2024.
3
sFgl2-Treg Positive Feedback Pathway Protects against Atherosclerosis.sFgl2-Treg 正反馈通路可预防动脉粥样硬化。
Int J Mol Sci. 2023 Jan 25;24(3):2338. doi: 10.3390/ijms24032338.
本文引用的文献
1
Adoptive transfer of CX3CR1 transduced-T regulatory cells improves homing to the atherosclerotic plaques and dampens atherosclerosis progression.过继转移CX3CR1转导的调节性T细胞可改善归巢至动脉粥样硬化斑块的情况，并抑制动脉粥样硬化进展。
Cardiovasc Res. 2021 Jul 27;117(9):2069-2082. doi: 10.1093/cvr/cvaa264.
2
T cell-based therapies: challenges and perspectives.基于 T 细胞的疗法：挑战与展望。
Nat Rev Immunol. 2020 Mar;20(3):158-172. doi: 10.1038/s41577-019-0232-6. Epub 2019 Dec 6.
3
Immunity and Inflammation in Atherosclerosis.动脉粥样硬化中的免疫与炎症。
Circ Res. 2019 Jan 18;124(2):315-327. doi: 10.1161/CIRCRESAHA.118.313591.
4
Atherosclerosis.动脉粥样硬化
Circ Res. 2018 Oct 26;123(10):1118-1120. doi: 10.1161/CIRCRESAHA.118.313816.
5
Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization.调节性T细胞的最低信息要求：迈向可重复性和标准化的一步。
Front Immunol. 2018 Jan 15;8:1844. doi: 10.3389/fimmu.2017.01844. eCollection 2017.
6
CCR5+T-bet+FoxP3+ Effector CD4 T Cells Drive Atherosclerosis.CCR5+T-bet+FoxP3+效应性CD4 T细胞驱动动脉粥样硬化。
Circ Res. 2016 May 13;118(10):1540-52. doi: 10.1161/CIRCRESAHA.116.308648. Epub 2016 Mar 28.
7
Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice.白细胞介素-17A 阻断可减少载脂蛋白 E 缺陷小鼠的动脉粥样硬化。
Circulation. 2010 Apr 20;121(15):1746-55. doi: 10.1161/CIRCULATIONAHA.109.924886. Epub 2010 Apr 5.
8
CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival.CX3CR1通过促进细胞存活，对单核细胞稳态和动脉粥样硬化形成是必需的。
Blood. 2009 Jan 22;113(4):963-72. doi: 10.1182/blood-2008-07-170787. Epub 2008 Oct 29.
9
Plasma-derived microparticles for biomarker discovery.用于生物标志物发现的血浆来源微粒。
Clin Lab. 2008;54(3-4):67-79.
Zotero 插件